• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 11
  • 3
  • 1
  • 1

PRICE

9
9
10
16

PUBLISHED

0
0
2
16

PRODUCT TYPE

16

Search "Sareum Ltd-Deals & Alliances Report" returned 16 results.

PRODUCT TITLE

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2013

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

August 2013
FROM
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2013 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2013 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2013

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

March 2013
FROM
Intestinal Cancer - Pipeline Review, H2 2012 Intestinal Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Intestinal Cancer - Pipeline Review, H2 2012

Intestinal Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Intestinal Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...

December 2012
FROM
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2012 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2012 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2012

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

August 2012
FROM

Colorectal Cancer - Pipeline Review, H2 2011

Colorectal Cancer - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Colorectal Cancer - Pipeline Review, H2 2011', provides an overview of the Colorectal Cancer therapeutic pipeline. This...

September 2011
FROM

Colon Cancers - Pipeline Review, Q1 2011

Colon Cancers - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Colon Cancers - Pipeline Review, Q1 2011', provides an overview of the Colon Cancers therapeutic pipeline. This report provides...

February 2011
FROM

Colorectal Cancer - Pipeline Review, Q1 2011

Colorectal Cancer - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Colorectal Cancer - Pipeline Review, Q1 2011', provides an overview of the Colorectal Cancer therapeutic pipeline. This...

February 2011
FROM
Gastrointestinal Tract Cancer - Pipeline Review, H2 2012 Gastrointestinal Tract Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Gastrointestinal Tract Cancer - Pipeline Review, H2 2012

Gastrointestinal Tract Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Gastrointestinal Tract Cancer - Pipeline Review, Global Markets Direct’s, 'Gastrointestinal Tract Cancer...

September 2012
FROM

Multiple Sclerosis - Pipeline Review, H2 2011

Multiple Sclerosis - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, H2 2011', provides an overview of the Multiple Sclerosis therapeutic pipeline....

September 2011
FROM

Melanoma - Pipeline Review, Q4 2010

Melanoma - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Melanoma Pipeline Review, Q4 2010”, provides an overview of the Melanoma therapeutic pipeline. This report provides information...

December 2010
FROM

Liver Cancer - Pipeline Review, Q3 2011

Liver Cancer - Pipeline Review, Q3 2011 Summary Global Markets Direct’s, 'Liver Cancer - Pipeline Review, Q3 2011', provides an overview of the Liver Cancer therapeutic pipeline. This report provides...

July 2011
FROM
Leukemias - Pipeline Review, H1 2012 Leukemias - Pipeline Review, H1 2012 - Product Thumbnail Image

Leukemias - Pipeline Review, H1 2012

Leukemias – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Leukemias - Pipeline Review, H1 2012', provides an overview of the Leukemias therapeutic pipeline. This report provides information...

January 2012
FROM

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

February 2014
FROM

Melanoma - Pipeline Review, H2 2011

Melanoma - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H2 2011', provides an overview of the Melanoma therapeutic pipeline. This report provides information...

September 2011
FROM

Non-Small Cell Lung Cancer - Pipeline Review, H2 2011

Non-Small Cell Lung Cancer - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Non-Small Cell Lung Cancer - Pipeline Review, H2 2011', provides an overview of the Non-Small Cell Lung Cancer...

September 2011
FROM
Antivirals - Global Strategic Business Report Antivirals - Global Strategic Business Report - Product Thumbnail Image

Antivirals - Global Strategic Business Report

This report analyzes the worldwide markets for Antivirals in US$ Million The major product segments analyzed are HIV Antivirals (Reverse Transcriptase Inhibitors (RTIs) (Nucleotide Reverse Transcriptase...

October 2006
FROM
Loading Indicator